Moleculin Biotech Inc (MBRX)

Jan 07, 2026

Why retail investors favor Moleculin Biotech Inc. stockEarnings Miss Alerts & Free Fast Track Wealth Growth - ulpravda.ru

Jan 07, 2026

Jan 07, 2026

Why Moleculin Biotech Inc. stock is considered a top pickMarket Insider Reports & Budget Friendly Trading Strategies - ulpravda.ru

Jan 07, 2026

Jan 07, 2026

Moleculin Biotech regains Nasdaq listing compliance - MarketScreener

Jan 07, 2026

Jan 07, 2026

Moleculin Biotech Regains Compliance With Nasdaq Listing Requirements - TipRanks

Jan 07, 2026

Jan 07, 2026

Moleculin Biotech Regains Nasdaq Compliance - TradingView — Track All Markets

Jan 07, 2026

Jan 06, 2026

Why Moleculin Biotech Inc. stock remains a top recommendation2026 world cup usa national team round of 32 midfield engines counter attacking tactical prediction breakdown - ulpravda.ru

Jan 06, 2026

Jan 04, 2026

Moleculin shares rise 6% as enrollment nears key milestone in AML trial - MSN

Jan 04, 2026

Jan 03, 2026

Moleculin Biotech’s Wild Ride: Is Tiny-Cap MBRX the Next Viral Moonshot or Total Trap? - AD HOC NEWS

Jan 03, 2026

Jan 02, 2026

MBRX stock touches 52-week low at $1.46 amid sharp yearly decline - MSN

Jan 02, 2026

Dec 31, 2025

Moleculin Biotech enters inducement offer agreements - MSN

Dec 31, 2025

Dec 30, 2025

Moleculin Biotech Inc. (MBRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 30, 2025

Dec 29, 2025

Moleculin Biotech begins dosing subjects in combination therapy trial for AML - MSN

Dec 29, 2025

Dec 22, 2025

Moleculin Biotech amends warrants and reports stockholders’ equity above $10 million - Investing.com Nigeria

Dec 22, 2025

Dec 22, 2025

Moleculin Biotech amends warrants and reports stockholders’ equity above $10 million By Investing.com - Investing.com South Africa

Dec 22, 2025

Dec 22, 2025

Moleculin Biotech Amends Warrants to Boost Nasdaq Compliance - TipRanks

Dec 22, 2025

Dec 22, 2025

Moleculin Biotech Signs Warrant Amendment Agreements With Holders of Series E, F and G Warrants - TradingView — Track All Markets

Dec 22, 2025

Dec 20, 2025

Moleculin Biotech shares slide after release of pediatric brain tumor trial data - MSN

Dec 20, 2025

Dec 20, 2025

Will Moleculin Biotech Inc. stock rally after Fed decisions2025 Volatility Report & Long Hold Capital Preservation Tips - Улправда

Dec 20, 2025

Dec 20, 2025

Will Moleculin Biotech Inc. stock split attract more investorsMarket Performance Report & Safe Capital Growth Plans - Улправда

Dec 20, 2025

Dec 20, 2025

Moleculin Biotech Earnings Notes - Trefis

Dec 20, 2025

Dec 19, 2025

Moleculin Biotech (LTS:0K2H) EV-to-OCF : -0.07 (As of Dec. 19, 2025) - GuruFocus

Dec 19, 2025

Dec 19, 2025

How risky is Moleculin Biotech Inc. (MOL) stock compared to peersJuly 2025 Spike Watch & Target Return Focused Picks - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Why Moleculin Biotech Inc. (MOL) stock is listed among top recommendationsJuly 2025 PreEarnings & Technical Pattern Based Signals - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Earnings Report: Why Moleculin Biotech Inc. stock is considered a top pickJuly 2025 Snapshot & Weekly Setup with High ROI Potential - Улправда

Dec 19, 2025

Dec 19, 2025

Market Review: Why Moleculin Biotech Inc. stock could rally in 2025July 2025 Snapshot & Fast Gain Swing Alerts - DonanımHaber

Dec 19, 2025

Dec 19, 2025

What technical charts say about Moleculin Biotech Inc. stockMarket Risk Analysis & Smart Swing Trading Alerts - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Why Moleculin Biotech Inc. stock could rally in 2025Global Markets & Verified Momentum Stock Watchlist - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Aug Wrap: Why Moleculin Biotech Inc. stock is considered a top pickJuly 2025 Rallies & Stepwise Entry and Exit Trade Signals - Улправда

Dec 19, 2025

Dec 18, 2025

Why Moleculin Biotech Inc. stock is popular among millennialsWeekly Market Outlook & High Accuracy Swing Trade Signals - Улправда

Dec 18, 2025

Dec 18, 2025

Why hedge funds are buying Moleculin Biotech Inc. stockTrade Risk Summary & Accurate Trade Setup Notifications - ulpravda.ru

Dec 18, 2025

Dec 18, 2025

Moleculin Biotech reports positive phase 1 trial results - MSN

Dec 18, 2025

Dec 18, 2025

Moleculin Biotech stock falls after pediatric brain tumor trial results By Investing.com - Investing.com Australia

Dec 18, 2025

Dec 17, 2025

Moleculin Biotech’s Bold Move: Stock Split Announced - StocksToTrade

Dec 17, 2025

Dec 17, 2025

Moleculin’s brain cancer drug shows promise in pediatric trial By Investing.com - Investing.com Nigeria

Dec 17, 2025

Dec 17, 2025

Moleculin Shares Drop 17% Despite Positive Phase 1 WP1066 Data In Pediatric Brain Tumors - Nasdaq

Dec 17, 2025

Dec 17, 2025

Moleculin Biotech Prepares for 1-for-25 Reverse Split Amidst Clinical Advancements - timothysykes.com

Dec 17, 2025

Dec 17, 2025

Moleculin Biotech regains Nasdaq compliance - MSN

Dec 17, 2025

Dec 17, 2025

Moleculin's WP1066 Shows Immune Activity, Favorable Safety In Pediatric Brain Cancer Trial - Nasdaq

Dec 17, 2025

Dec 17, 2025

Moleculin announces positive phase 1 data for WP1066 in pediatric brain tumors - marketscreener.com

Dec 17, 2025

Dec 17, 2025

Moleculin Biotech’s Reverse Split Shocks Market - timothysykes.com

Dec 17, 2025

Dec 17, 2025

Moleculin’s brain cancer drug shows promise in pediatric trial - Investing.com

Dec 17, 2025

Dec 17, 2025

Moleculin Biotech stock falls after pediatric brain tumor trial results - Investing.com

Dec 17, 2025

Dec 17, 2025

Moleculin Biotech Reports Positive Phase 1 Trial Results - TipRanks

Dec 17, 2025